Assertio Holdings, Inc. Common Stock (ASRT) Stock Price

ASRTStock
$0.0058.08%52W
Market Cap
P/E
PEG Ratio0.89
Div yield
Beta-0.31

ASRT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)90.44%
Price vs S&P 500 (4W)-1.42%
PEG Ratio0.89
VGM Score49.49

ASRT Earnings Surprise History

Q2 250.30est. -0.07
Q3 252.70est. 0.00
Q4 25-1.06est. -1.80

ASRT Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.80
3.80
3.80
3.80

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ASRTAssertio Holdings, Inc. Common Stock
BDB$0.00
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Assertio Holdings, Inc. Common Stock

Assertio Holdings is a specialty pharmaceutical company focused on neurology and pain management. It markets three FDA-approved products: Gralise for postherpetic neuralgia, CAMBIA for acute migraine treatment, and Zipsor for mild to moderate pain relief.